Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 415

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis

Wisdom, Nick M., Callahan, Jennifer L., Hawkins, Keith A.·2011·Neurobiology of Aging

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2009.02.003

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 95

  1. *Alexander, 2007, The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades, Biol. Psychol., 75, 229, 10.1016/j.biopsycho.2007.03.001 · DOI
  2. *Askar, 2005, Apolipoprotein E epsilon4 allele and neurobehavioral status after on-pump coronary artery bypass grafting, J. Card. Surg., 20, 501, 10.1111/j.1540-8191.2005.2004138.x · DOI
  3. Bachman, 1992, Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study, Neurology, 42, 115, 10.1212/WNL.42.1.115 · DOI · Paper page
  4. *Bartzokis, 2006, Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia, Arch. Gen. Psychiatry, 63, 63, 10.1001/archpsyc.63.1.63 · DOI
  5. *Bathum, 2006, Apolipoprotein e genotypes: relationship to cognitive functioning, cognitive decline, and survival in nonagenarians, J. Am. Geriatr. Soc., 54, 654, 10.1111/j.1532-5415.2005.53554.x · DOI
  6. *Berr, 1996, Early effect of ApoE-epsilon 4 allele on cognitive results in a group of highly performing subjects: the EVA study, Neurosci. Lett., 218, 9, 10.1016/0304-3940(96)13059-7 · DOI
  7. *Blair, 2005, APOE genotype and cognitive decline in a middle-aged cohort, Neurology, 64, 268, 10.1212/01.WNL.0000149643.91367.8A · DOI · Paper page
  8. Bretsky, 2003, The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur studies of successful aging, Neurology, 60, 1077, 10.1212/01.WNL.0000055875.26908.24 · DOI · Paper page
  9. *Bunce, 2005, Apolipoprotein E, B vitamins, and cognitive function in older adults, J. Gerontol. B Psychol. Sci. Soc. Sci., 60, 41, 10.1093/geronb/60.1.P41 · DOI
  10. *Burkhardt, 2004, Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4, J. Alzheimers Dis., 6, 221, 10.3233/JAD-2004-6302 · DOI
  11. Cacabelos, 2003, The application of functional genomics to Alzheimer's disease, Pharmacogenomics, 4, 597, 10.1517/phgs.4.5.597.23795 · DOI
  12. *Calhoun-Haney, 2005, Apolipoprotein epsilon4 is associated with more rapid decline in odor identification than in odor threshold or Dementia Rating Scale scores, Brain Cogn., 58, 178, 10.1016/j.bandc.2004.10.004 · DOI
  13. *Caselli, 2002, A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE ɛ4 homozygotes, Sleep, 25, 447
  14. Corder, 1996, Attenuation of apolipoprotein E epsilon 4 allele gene dose in late age, Lancet, 347, 542, 10.1016/S0140-6736(96)91173-3 · DOI
  15. Corder, 2008, Genetic susceptibility sets for Alzheimer's disease identified from diverse candidate loci, Rejuvenat. Res., 11, 667, 10.1089/rej.2008.0742 · DOI
  16. Corder, 2008, Alzheimer pathogenesis for men and women, Alzheimer Dis. Res. J., 2, 39
  17. Corder, 1996, Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition, Arch. Neurol., 53, 418, 10.1001/archneur.1996.00550050048022 · DOI
  18. Corder, 1995, Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease, Neurology, 45, 1323, 10.1212/WNL.45.7.1323 · DOI · Paper page
  19. *Deary, 2002, Cognitive change and the APOE epsilon 4 allele, Nature, 418, 932, 10.1038/418932a · DOI · Paper page
  20. *Deeny, 2008, Exercise, APOE, and working memory: MEG and behavioral evidence for benefit of exercise in epsilon4 carriers, Biol. Psychol., 78, 179, 10.1016/j.biopsycho.2008.02.007 · DOI · Paper page
  21. *den Heijer, 2002, Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes, Neurology, 59, 746, 10.1212/WNL.59.5.746 · DOI · Paper page
  22. *Dik, 2000, APOE-epsilon4 is associated with memory decline in cognitively impaired elderly, Neurology, 54, 1492, 10.1212/WNL.54.7.1492 · DOI
  23. *Driscoll, 2005, Apolipoprotein E and prospective memory in normally aging adults, Neuropsychology, 19, 28, 10.1037/0894-4105.19.1.28 · DOI
  24. *Espeseth, 2008, Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4, Neurobiol. Aging, 29, 329, 10.1016/j.neurobiolaging.2006.10.030 · DOI
  25. Evans, 1990, Estimated prevalence of Alzheimer's disease in the United States, Milbank Q, 68, 267, 10.2307/3350099 · DOI · Paper page
  26. *Flicker, 2004, Homocysteine, Alzheimer genes and proteins, and measures of cognition and depression in older men, J. Alzheimers Dis., 6, 329, 10.3233/JAD-2004-6313 · DOI
  27. *Flory, 2000, Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults, Am. J. Med. Genet., 96, 707, 10.1002/1096-8628(20001204)96:6<707::AID-AJMG1>3.0.CO;2-V · DOI
  28. *Frisoni, 2005, Structural correlates of early and late onset Alzheimer's disease: voxel based morphometric study, J. Neurol. Neurosurg. Psychiatry, 76, 112, 10.1136/jnnp.2003.029876 · DOI · Paper page
  29. *Gilbert, 2004, The effect of the ApoE epsilon4 allele on recognition memory for olfactory and visual stimuli in patients with pathologically confirmed Alzheimer's disease, probable Alzheimer's disease, and healthy elderly controls, J. Clin. Exp. Neuropsychol., 26, 779, 10.1080/13803390490509439 · DOI
  30. Hall, 1991, Testing for moderating variables in meta-analysis: Issues and methods, Commun. Monogr., 58, 437, 10.1080/03637759109376240 · DOI
  31. Hawkins, 1996, Limitations of cognitive status exams: a case-based discussion, Psychiatry, 59, 382, 10.1080/00332747.1996.11024777 · doi:10.1080/00332747.1996.11024777
  32. *Helkala, 1995, The association of apolipoprotein E polymorphism with memory: a population based study, Neurosci. Lett., 191, 141, 10.1016/0304-3940(95)11575-H · DOI
  33. Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
  34. Hirono, 2003, Accelerated memory decline in Alzheimer's disease with Apolipoprotein epsilon 4 allele, J. Neuropsychiatry Clin. Neurosci., 15, 354, 10.1176/appi.neuropsych.15.3.354 · DOI
  35. *Hofer, 2002, Change in cognitive functioning associated with apoE genotype in a community sample of older adults, Psychol. Aging, 17, 194, 10.1037/0882-7974.17.2.194 · DOI
  36. *Houston, 2005, Executive function asymmetry in older adults genetically at-risk for Alzheimer's disease: verbal versus design fluency, J. Int. Neuropsychol. Soc., 11, 863, 10.1017/S1355617705051015 · DOI
  37. *Hu, 2006, Association between serum beta-carotene levels and decline of cognitive function in high-functioning older persons with or without apolipoprotein E 4 alleles: MacArthur studies of successful aging, J. Gerontol. A Biol. Sci. Med. Sci., 61, 616, 10.1093/gerona/61.6.616 · DOI
  38. *Hwang, 2006, Association of APOE genetic polymorphism with cognitive function and suicide history in geriatric depression, Dement. Geriatr. Cogn. Disord., 22, 334, 10.1159/000095599 · DOI
  39. *Irie, 2008, Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study, Arch. Neurol., 65, 89, 10.1001/archneurol.2007.29 · DOI · Paper page
  40. *Jessen, 2007, Patterns of subjective memory impairment in the elderly: association with memory performance, Psychol. Med., 37, 1753, 10.1017/S0033291707001122 · DOI · Paper page
  41. Johnson, 1995, Comparison of three major meta-analytic approaches, Journal of, Appl. Psychol., 80, 94, 10.1037/0021-9010.80.1.94 · DOI
  42. *Johnson, 2006, The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation, J. Neurosci., 26, 6069, 10.1523/JNEUROSCI.0959-06.2006 · DOI
  43. *Jorm, 2007, APOE genotype and cognitive functioning in a large age-stratified population sample, Neuropsychology, 21, 1, 10.1037/0894-4105.21.1.1 · DOI
  44. *Juva, 2000, Apolipoprotein E, cognitive function, and dementia in a general population aged 85 years and over, Int. Psychogeriatr., 12, 379, 10.1017/S1041610200006487 · DOI
  45. Kamboh, 2006, Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures, Mol. Psychiatry, 11, 273, 10.1038/sj.mp.4001775 · DOI
  46. *Kim, 2002, Apolipoprotein E epsilon 4 allele is not associated with the cognitive impairment in community-dwelling normal elderly individuals, Int. J. Geriatr. Psychiatry, 17, 635, 10.1002/gps.664 · DOI
  47. *Klages, 2003, APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging, Dement. Geriatr. Cogn. Disord., 15, 1, 10.1159/000066670 · DOI
  48. *Kryscio, 2006, Risk factors for transitions from normal to mild cognitive impairment and dementia, Neurology, 66, 828, 10.1212/01.wnl.0000203264.71880.45 · DOI · Paper page
  49. Lahiri, 2004, Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease, Neurobiol. Aging, 25, 651, 10.1016/j.neurobiolaging.2003.12.024 · DOI
  50. *Lehmann, 2006, Apolipoprotein E epsilon4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference. The Hordaland Health Study, J. Neurol. Neurosurg. Psychiatry, 77, 902, 10.1136/jnnp.2005.077818 · DOI
  51. *Levy, 2004, Context-specific memory and apolipoprotein E (ApoE) epsilon 4: cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease, J. Int. Neuropsychol. Soc., 10, 362, 10.1017/S1355617704103044 · DOI
  52. Licastro, 2007, Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation, Neurobiol. Aging, 28, 1637, 10.1016/j.neurobiolaging.2006.07.007 · DOI
  53. Marra, 2004, Apolipoprotein E epsilon 4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients, Dement. Geriatr. Cogn. Disord., 18, 125, 10.1159/000079191 · DOI
  54. Martins, 2005, APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model, Neurology, 65, 1888, 10.1212/01.wnl.0000188871.74093.12 · DOI · Paper page
  55. *Moffat, 2000, Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype, Neurology, 55, 134, 10.1212/WNL.55.1.134 · DOI · Paper page
  56. *Mondadori, 2007, Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers, Cereb. Cortex, 17, 1934, 10.1093/cercor/bhl103 · DOI · Paper page
  57. *Moore, 2005, Eyeblink classical conditioning to auditory and olfactory stimuli: performance among older adults with and without the apolipoprotein E epsilon 4 allele, Neuropsychology, 19, 437, 10.1037/0894-4105.19.4.437 · DOI
  58. *Mosconi, 2008, Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints, Biol. Psychiatry, 63, 609, 10.1016/j.biopsych.2007.05.030 · DOI · Paper page
  59. *Newman, 2000, Talkativeness in cognitively normal women at genetic risk for Alzheimer's disease, Aging Neuropsychol. Cogn., 7, 217, 10.1076/anec.7.4.217.797 · DOI
  60. *Nilsson, 2006, The influence of APOE status on episodic and semantic memory: data from a population-based study, Neuropsychology, 20, 645, 10.1037/0894-4105.20.6.645 · DOI
  61. *O’Hara, 1998, The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults, J. Am. Geriatr. Soc., 46, 1493, 10.1111/j.1532-5415.1998.tb01532.x · DOI
  62. Parker, 2005, Apolipoprotein gene E4 allele promoter polymorphisms as risk factors for Alzheimer's disease, Psychiatr. Genet., 15, 271, 10.1097/00041444-200512000-00009 · DOI
  63. *Payton, 2006, Influence and interactions of cathepsin D, HLA-DRB1 and APOE on cognitive abilities in an older non-demented population, Genes Brain Behav., 5, 23, 10.1111/j.1601-183X.2006.00191.x · DOI
  64. *Peavy, 2007, The effects of prolonged stress and APOE genotype on memory and cortisol in older adults, Biol. Psychiatry, 62, 472, 10.1016/j.biopsych.2007.03.013 · DOI
  65. *Persson, 2006, Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD?, Neurology, 66, 1029, 10.1212/01.wnl.0000204180.25361.48 · DOI · Paper page
  66. Plassman, 1996, Apolipoprotein E and cognitive decline in Alzheimer's disease, Neurology, 47, 317, 10.1212/WNL.47.2.317 · DOI
  67. *Plassman, 1997, Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition, Neurology, 48, 985, 10.1212/WNL.48.4.985 · DOI
  68. *Pomara, 2005, Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults, Arch. Gen. Psychiatry, 62, 209, 10.1001/archpsyc.62.2.209 · DOI
  69. *Reynolds, 2006, Longitudinal memory performance during normal aging: twin association models of APOE and other Alzheimer candidate genes, Behav. Genet., 36, 185, 10.1007/s10519-005-9027-6 · DOI
  70. *Riley, 2000, Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study, J. Gerontol. B Psychol. Sci. Soc. Sci., 55, S69, 10.1093/geronb/55.2.S69 · DOI
  71. *Robson, 2002, Apolipoprotein E and neurocognitive outcome from coronary artery surgery, J. Neurol. Neurosurg. Psychiatry, 72, 675, 10.1136/jnnp.72.5.675 · DOI
  72. Rocchi, 2003, Causative and susceptibility genes for Alzheimer's disease: a review, Brain Res. Bull., 61, 1, 10.1016/S0361-9230(03)00067-4 · DOI · Paper page
  73. *Rosen, 2002, Working memory and apolipoprotein E: what's the connection?, Neuropsychologia, 40, 2226, 10.1016/S0028-3932(02)00132-X · DOI
  74. *Sager, 2005, Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention, J. Geriatr. Psychiatry Neurol., 18, 245, 10.1177/0891988705281882 · DOI · Paper page
  75. *Salo, 2001, Does apolipoprotein E influence learning and memory in the nondemented oldest old?, Int. Psychogeriatr., 13, 451, 10.1017/S1041610201007864 · DOI
  76. *Savitz, 2007, Genotype and childhood sexual trauma moderate neurocognitive performance: a possible role for brain-derived neurotrophic factor and apolipoprotein E variants, Biol. Psychiatry, 62, 391, 10.1016/j.biopsych.2006.10.017 · DOI
  77. *Schmidt, 1996, Apolipoprotein E ɛ4 allele in the normal elderly: neuropsychologic and brain MRI correlates, Clin. Genet., 50, 293, 10.1111/j.1399-0004.1996.tb02377.x · DOI
  78. *Small, 1998, Three-year changes in cognitive performance as a function of apolipoprotein E genotype: evidence from very old adults without dementia, Psychol. Aging, 13, 80, 10.1037/0882-7974.13.1.80 · doi:10.1037/0882-7974.13.1.80
  79. *Small, 2000, Is APOE—epsilon4 a risk factor for cognitive impairment in normal aging?, Neurology, 54, 2082, 10.1212/WNL.54.11.2082 · DOI
  80. Small, 2004, Apolipoprotein E and cognitive performance: a meta-analysis, Psychol. Aging, 19, 592, 10.1037/0882-7974.19.4.592 · DOI · Paper page
  81. *Smith, 1998, Apolipoprotein E genotype influences cognitive ‘phenotype’ in patients with Alzheimer's disease but not in healthy control subjects, Neurology, 50, 355, 10.1212/WNL.50.2.355 · DOI · Paper page
  82. *Steed, 2001, The role of apolipoprotein E in cognitive decline after cardiac operation, Ann. Thorac. Surg., 71, 823, 10.1016/S0003-4975(00)02511-X · DOI
  83. *Sun, 2007, Decreased cerebral blood flow velocity in apolipoprotein E epsilon4 allele carriers with mild cognitive impairment, Eur. J. Neurol., 14, 150, 10.1111/j.1468-1331.2006.01579.x · DOI
  84. *Swan, 2005, Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults, J. Geriatr. Psychiatry Neurol., 18, 196, 10.1177/0891988705281864 · DOI
  85. *Tagarakis, 2007, The role of apolipoprotein E in cognitive decline and delirium after bypass heart operations, Am. J. Alzheimers Dis. Other Demen., 22, 223, 10.1177/1533317507299415 · DOI
  86. *Tardiff, 1997, Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center, Ann. Thorac. Surg., 64, 715, 10.1016/S0003-4975(97)00757-1 · DOI · Paper page
  87. *Tohgi, 1997, Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele, Neurosci. Lett., 236, 21, 10.1016/S0304-3940(97)00743-X · DOI
  88. *Tupler, 2007, Predicting memory decline in normal elderly: genetics, MRI, and cognitive reserve, Neurobiol. Aging, 28, 1644, 10.1016/j.neurobiolaging.2006.07.001 · DOI
  89. van der Cammen, 2004, Genetic testing has no place as a routine diagnostic test in sporadic and familial cases of Alzheimer's disease, J. Am. Geriatr. Soc., 52, 2110, 10.1111/j.1532-5415.2004.52573.x · DOI
  90. *Wang, 2006, Prediction of Alzheimer's disease in mild cognitive impairment: a prospective study in Taiwan, Neurobiol. Aging, 27, 1797, 10.1016/j.neurobiolaging.2005.10.002 · DOI
  91. *Wilson, 2002, The apolipoprotein E epsilon 2 allele and decline in episodic memory, J. Neurol. Neurosurg. Psychiatry, 73, 672, 10.1136/jnnp.73.6.672 · DOI · Paper page
  92. *Wilson, 2002, The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period, Arch. Neurol., 59, 1154, 10.1001/archneur.59.7.1154 · DOI · Paper page
  93. *Wishart, 2006, Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele, Am. J. Psychiatry, 163, 1603, 10.1176/appi.ajp.163.9.1603 · doi:10.1176/appi.ajp.163.9.1603
  94. *Yaffe, 1997, Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women, Arch. Neurol., 54, 1110, 10.1001/archneur.1997.00550210044011 · DOI
  95. Yip, 2002, Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population, J. Med. Genet., 39, 639, 10.1136/jmg.39.9.639 · DOI

Cited by

See all 415

Metadata

Authors
Wisdom, N. M., Callahan, J. L., & Hawkins, K. A.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2011-01
Volume
32
Issue
1
Pages
63-74
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2009339691
Cited by
415
References
14
FWCI
2.55
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2009.02.003
The paper
Wisdom, N. M., Callahan, J. L., & Hawkins, K. A. (2011). The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2009.02.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.